The aim of this study was to establish a thrombin generation assay (calibrated automated thrombogram, CAT) in cats by determining the precision (repeatability), reference values, and the sensitivity to anticoagulant treatment with the factor Xa inhibitor apixaban. The CAT method was performed on citrated plasma with different commercial tissue factor (TF) reagents (PPP Reagent 1 pM [LOW], PPP Reagent 5 pM, PPP Reagent 20 pM [HIGH]) according to the manufacturers` test instruction. Measurements in triplicate were performed in platelet poor plasma (PPP) of 58 healthy cats and in 6 cats at different times following the oral administration of 2.5 mg apixaban. The median CVs in healthy cats usually were < 10% with the exception of thrombin peak height measured using PPP Reagent 1 pM (14.6%). Reference values of all parameters showed marked inter-individual variability and depended largely on the TF concentration of the used activating reagent. Thrombin generation was significantly influenced by apixaban and reacted more sensitively than other tests of haemostasis including the prothrombin time, aPTT, and rotational elastometry. In conclusion, thrombin generation measured by the CAT method using commercially available reagents seems suitable for the examination of feline PPP and may be a valuable method to establish effective anticoagulant therapies for the feline patient and monitoring of such therapies in cats.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.rvsc.2019.08.030 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Assessment of Platelet Aggregation and Thrombin Generation in Patients with Familial Chylomicronemia Syndrome Treated with Volanesorsen: A Cross-Sectional Study.
Biomedicines
September 2024
Department of Clinical Medicine and Surgery, Federico II University of Naples, 80131 Naples, Italy.
Background: The antisense oligonucleotide against APOC3 mRNA volanesorsen was recently introduced to treat Familial Chylomicronemia Syndrome (FCS). Cases of decreased platelet count are reported among patients treated with volanesorsen. The aim of the study was to evaluate platelet function and thrombin generation (TG) assessment in FCS patients receiving volanesorsen.
View Article and Find Full Text PDFAssessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis.
JMIR Public Health Surveill
September 2024
Microbiology Department, Complexo Hospitalario Universitario de Vigo, Servicio Galego de Saude, Vigo, Spain.
Background: The development of new large-scale saliva pooling detection strategies can significantly enhance testing capacity and frequency for asymptomatic individuals, which is crucial for containing SARS-CoV-2.
Objective: This study aims to implement and scale-up a SARS-CoV-2 screening method using pooled saliva samples to control the virus in critical areas and assess its effectiveness in detecting asymptomatic infections.
Methods: Between August 2020 and February 2022, our laboratory received a total of 928,357 samples.
PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?
Theranostics
July 2024
Department of Nuclear Medicine and German Cancer Consortium (DKTK), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Prostate Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) is routinely used for the staging of patients with prostate cancer, but data on response assessment are sparse and primarily stem from metastatic castration-resistant prostate cancer (mCRPC) patients treated with PSMA radioligand therapy. Still, follow-up PSMA-PET is employed in earlier disease stages in case of clinical suspicion of disease persistence, recurrence or progression to decide if localized or systemic treatment is indicated. Therefore, the prognostic value of PSMA-PET derived tumor volumes in earlier disease stages (i.
View Article and Find Full Text PDFNon-clinical investigations about cytotoxic and anti-platelet activities of gamma-terpinene.
Naunyn Schmiedebergs Arch Pharmacol
October 2024
Postgraduate Program in Pharmacology, Center for Research on Medicinal Plants (NPPM), Federal University of Piauí, Teresina, 64049-550, Brazil.
Article Synopsis
- Gamma-terpinene (γ-TPN), a monoterpene found in various plant essential oils (like tea tree and oregano), shows potential pharmacological effects on the cardiovascular system and antioxidant activities.
- The study investigated γ-TPN's cytotoxic effects and ability to reduce platelet aggregation using laboratory models, including MTT assays and platelet-rich plasma from hypertensive rats.
- Results indicated that γ-TPN has good lipid solubility, potential bioavailability, and favorable interaction with purinergic receptors, suggesting it may be promising for further research in managing thromboembolism and oxidative stress.
Endogenous thrombin potential and time-dependent thrombin generation parameters are independent risk factors for mortality in the general population.
J Thromb Haemost
June 2024
Department of Epidemiology and Prevention, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Neuromed, Pozzilli, Italy; Department of Medicine and Surgery, Libera Università Mediterranea (LUM) University "Giuseppe Degennaro", Casamassima, Italy.
Article Synopsis
- Thrombin generation (TG) is a test for coagulation that helps assess the risk of thrombosis and bleeding, but its link to mortality has been unclear until this study.
- This research examined the relationship between TG and mortality in a large cohort of nearly 22,000 people, measuring various TG parameters and adjusting for factors like age and medical history.
- The findings revealed that lower levels of endogenous thrombin potential (ETP) and a high time-to-peak/lag time (TTP/LT) ratio are associated with higher all-cause mortality, indicating these factors could be important independent risk indicators.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!